The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know

被引:43
作者
Doycheva, Iliana [1 ]
Leise, Michael D. [2 ]
Watt, Kymberly D. [2 ]
机构
[1] Med Univ Sofia, Div Gastroenterol & Hepatol, Sofia, Bulgaria
[2] Mayo Clin, Div Gastroenterol & Hepatol, Transplant Ctr, Rochester, MN 55905 USA
关键词
SELECTIVE BOWEL DECONTAMINATION; HUMAN GUT MICROBIOME; BACTERIAL OVERGROWTH; BARRIER FUNCTION; ACUTE REJECTION; CIRRHOTIC RATS; INFECTION; HOMEOSTASIS; PROBIOTICS; IMPACT;
D O I
10.1097/TP.0000000000001008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The intestinal microbiome and immune system are in close symbiotic relationship in health. Gut microbiota plays a role in many chronic liver diseases and cirrhosis. However, alterations in the gut microbiome after liver transplantation and the implications for liver transplant recipients are not well understood and rely mainly on experimental animal studies. Recent advances in molecular techniques have identified that increased intestinal permeability, decreased beneficial bacteria, and increased pathogenic species may play important roles in the early posttransplant period. The associations between microbiota perturbation and postliver transplant infections and acute rejection are evolving. The link with metabolic syndrome, obesity, and cardiac disease in the general population require translation into the transplant recipient. This review focuses on our current knowledge of the known and potential interaction of the microbiome in the liver transplant recipient. Future human studies focused on microbiota changes in liver transplant patients are warranted and expected.
引用
收藏
页码:61 / 68
页数:8
相关论文
共 50 条
  • [31] COVID-19 and healthcare worker: What we need to know
    Jakhar, Deepak
    Grover, Chander
    Kour, Ishmeet
    Das, Anupam
    Kaul, Subuhi
    INDIAN JOURNAL OF DERMATOLOGY, 2021, 66 (03) : 264 - 271
  • [32] Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know
    Sun, Chuan-bin
    Wang, Yue-ye
    Liu, Geng-hao
    Liu, Zhe
    FRONTIERS IN PUBLIC HEALTH, 2020, 8
  • [33] Gut microbiome and Alzheimer's disease: What we know and what remains to be explored
    Kapoor, Bhupinder
    Biswas, Pratim
    Gulati, Monica
    Rani, Pooja
    Gupta, Reena
    AGEING RESEARCH REVIEWS, 2024, 102
  • [34] Innovation and entrepreneurship in Latin America: What do we know? What would we like to know?
    Alvarez, Roberto
    Grazzi, Matteo
    ESTUDIOS DE ECONOMIA, 2018, 45 (02): : 157 - 171
  • [35] Use of Antiretrovirals for HIV Prevention: What Do We Know and What Don't We Know?
    Baeten, Jared M.
    Grant, Robert
    CURRENT HIV/AIDS REPORTS, 2013, 10 (02) : 142 - 151
  • [36] Productive effects of public works programs: What do we know? What should we know?
    Gehrke, Esther
    Hartwig, Renate
    WORLD DEVELOPMENT, 2018, 107 : 111 - 124
  • [37] MORAL HAZARD IN HEALTH INSURANCE: WHAT WE KNOW AND HOW WE KNOW IT
    Einav, Liran
    Finkelstein, Amy
    JOURNAL OF THE EUROPEAN ECONOMIC ASSOCIATION, 2018, 16 (04) : 957 - 982
  • [38] How Can We Know What We Think We Know about Cyber Operations?
    Lilli, Eugenio
    JOURNAL OF GLOBAL SECURITY STUDIES, 2023, 8 (02)
  • [39] A Decade of College Student Hunger: What We Know and Where We Need to Go
    Hagedorn-Hatfield, Rebecca L.
    Hood, Lanae B.
    Hege, Adam
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [40] Autoimmune Hepatitis in Iran: What We Know, What We Don't Know and Requirements for Better Management
    Shafiei, Mostafa
    Alavian, Sayed Moayed
    HEPATITIS MONTHLY, 2012, 12 (02) : 73 - 76